Acurx Pharmaceuticals, Inc. (ACXP) Ownership
ACXP ownership summary
as of October 18, 2026- Institutions
- 3.6% of shares outstanding
- Insiders
- 2.31% of shares outstanding
- Shares outstanding
- 5.6M
- Float
- 5.1M shares available to trade
- Short interest
- 2.06% 112K shares short
- Days to cover
- 1.21 short interest down 10.0% vs prior month
- Institutions 3.65%
- Insiders 2.31%
- Other investors 94.04%
ACXP top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Vanguard Capital Management, LLC | 0.56% | 31K | $34,209 | — | June 30, 2026 |
| 2 | Geode Capital Management, LLC | 0.48% | 26K | $29,052 | +1,592 (+6.4%) | June 30, 2026 |
| 3 | Vanguard Fiduciary Trust Co | 0.29% | 16K | $17,826 | — | June 30, 2026 |
| 4 | Jane Street Group LLC | 0.28% | 16K | $17,300 | −38,915 (−71.2%) | June 30, 2026 |
| 5 | Prospect Financial Services Llc | 0.25% | 14K | $15,164 | — | June 30, 2026 |
| 6 | Morgan Stanley - Brokerage Accounts | 0.13% | 7,500 | $8,250 | +1,000 (+15.4%) | June 30, 2026 |
| 7 | Integrated Wealth Concepts LLC | 0.09% | 4,729 | $5,202 | +4,729 (0.0%) | June 30, 2026 |
| 8 | Tower Research Capital LLC | 0.05% | 2,744 | $3,018 | +1,713 (+166.1%) | June 30, 2026 |
| 9 | Wells Fargo & Co | 0.04% | 2,300 | $2,530 | — | June 30, 2026 |
| 10 | Westside Investment Management, Inc. | 0.03% | 1,650 | $1,815 | — | June 30, 2026 |
| 11 | Nbc Securities Inc | 0.03% | 1,500 | $1,650 | — | June 30, 2026 |
| 12 | Western Wealth Management, LLC | 0.02% | 1,325 | $1,458 | +1,325 (0.0%) | March 31, 2026 |
| 13 | Barclays PLC | 0.01% | 281 | $309 | −99 (−26.1%) | June 30, 2026 |
| 14 | Cornerstone Planning Group LLC | <0.01% | 167 | $184 | — | June 30, 2026 |
| 15 | Advisor Group Holdings, Inc. | <0.01% | 100 | $110 | — | June 30, 2026 |
| 16 | Group One Trading, LLC | <0.01% | 95 | $105 | −150 (−61.2%) | June 30, 2026 |
| 17 | BlackRock Inc | <0.01% | 60 | $66 | — | June 30, 2026 |
| 18 | Caitong International Asset Management Co., Limited. | <0.01% | 23 | $25 | +23 (0.0%) | June 30, 2026 |
| 19 | SBI Securities Co Ltd | <0.01% | 6 | $7 | — | June 30, 2026 |
| 20 | UBS Group AG | <0.01% | 3 | $3 | −6,309 (−100.0%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 6 holders added 10K shares and 4 cut 45K.
ACXP top mutual fund and ETF holders
3 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Fidelity Extended Market Index | 0.38% | 21K | $23,377 | −114 (−0.5%) | August 31, 2026 |
| 2 | Fidelity Series Total Market Index | 0.05% | 2,978 | $3,276 | — | August 31, 2026 |
| 3 | Fidelity Total Market Index | 0.02% | 1,001 | $1,101 | — | August 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
ACXP insider transactions
latest 2| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2025-01-06 | David P Luci | Buy | $20.20 | 2,463 | $49,753 |
| 2025-01-06 | Joseph C Scodari | Buy | $20.20 | 1,231 | $24,866 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
ACXP shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns ACXP
Institutional investors own 3.6% of Acurx Pharmaceuticals's shares and insiders 2.31%. The largest holder is Vanguard Capital Management, LLC with 0.56% of the shares (31K), as of June 30, 2026. Among the top 20 institutions, 6 added shares and 4 reduced their stake in the latest filings. Short interest is 2.06% of the float, or 1.21 days of average trading volume. The share count rose 214.2% since 2020.
Related: ACXP analyst forecast, ACXP key metrics. See the ACXP stock overview for the latest quote and news.
ACXP ownership FAQ
Who owns the most Acurx Pharmaceuticals stock?
The largest shareholders of Acurx Pharmaceuticals are Vanguard Capital Management, LLC (0.56%), Geode Capital Management, LLC (0.48%), Vanguard Fiduciary Trust Co (0.29%), Jane Street Group LLC (0.28%), Prospect Financial Services Llc (0.25%).
What percentage of Acurx Pharmaceuticals is owned by institutions?
Institutions hold 3.6% of Acurx Pharmaceuticals's shares outstanding; insiders hold 2.31%.
Which funds own Acurx Pharmaceuticals?
The largest fund holders of Acurx Pharmaceuticals are Fidelity Extended Market Index (0.38%), Fidelity Series Total Market Index (0.05%), Fidelity Total Market Index (0.02%).
What is Acurx Pharmaceuticals's short interest?
112K shares of Acurx Pharmaceuticals were sold short, 2.06% of the float; at the average daily volume it would take 1.21 days to cover.
Are insiders buying or selling Acurx Pharmaceuticals?
Of the latest 2 reported insider transactions in Acurx Pharmaceuticals (since January 6, 2025), 2 were purchases and 0 were sales.
How many shares of Acurx Pharmaceuticals are outstanding?
Acurx Pharmaceuticals has 5.6M shares outstanding, of which 5.1M are in the public float.